Qurient Co., Ltd. (KOSDAQ:115180)

Qurient Revenue

Qurient had revenue of 1.91B KRW in the quarter ending June 30, 2026, with 3.42% growth. This brings the company's total for the last twelve months to 7.07B, down -20.12% year-over-year. In the year 2025, Qurient had annual revenue of 6.98B, down -23.94%. That makes Qurient the 39,735th largest company in the world by revenue and 2,477th in South Korea.

• Revenue (ttm): 7.07B
• Revenue Growth: -20.12%
• P/S Ratio: 116.36
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 822.35B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Wholesale and Retail 9.17B 99.9%
• Pharmaceutical Research and Development 11.54M 0.1%

By Geography

Chart

• South Korea 9.17B 99.9%
• Overseas 11.54M 0.1%

Fiscal year ended Dec 31, 2024 See the full Qurient breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.98B	-2.20B	-23.94%
Dec 31, 2024	9.18B	148.03M	1.64%
Dec 31, 2023	9.03B	563.25M	6.65%
Dec 31, 2022	8.47B	3.58B	73.33%
Dec 31, 2021	4.89B	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error